Close Menu

NEW YORK ─ Auckland, New Zealand-based biotech firm Pictor said Monday it has received a NZ$500,000 ($300,000) grant from the Ministry of Business, Innovation, and Employment (MBIE) COVID-19 Innovation Acceleration Fund to develop a test for the detection of SARS-CoV-2 in less than an hour.

"Current diagnostic testing in New Zealand for COVID-19 is slow, complex, expensive, and must be done in a specialist central laboratory," Pictor CEO Howard Moore said in a statement.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.